Skip to content

Clinical trials

Phase 1/2 Lung Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1/2 Country / region: Spain Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20161
20174
20192
20201
20212
20235
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11
Completed6
Active, not recruiting4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
Eli Lilly and Company2
Revolution Medicines, Inc.2
Apexigen America, Inc.1
Blueprint Medicines Corporation1
Centocor, Inc.1
Grey Wolf Therapeutics1
Hoffmann-La Roche1
Incyte Corporation1
Inhatarget Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms22
Carcinoma, Non-Small-Cell Lung17
Neoplasms10
Colorectal Neoplasms9
Head and Neck Neoplasms8
Colonic Neoplasms6
Neoplasms by Site6
Bronchial Neoplasms5
Lung Diseases5
Neoplasm Metastasis5

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.